
    
      This is a single-center, randomized trial to assess the effects of 30 mg daily of tolvaptan
      when given concomitantly with home dose of diuretic (Lasix equivalent) intravenously (IV)
      versus 5mg daily of metolazone given concomitantly with home dose of diuretic (Lasix
      equivalent) IV, versus 2.5 times home dose of diuretic (Lasix equivalent) IV in participants
      hospitalized for acutely decompensated heart failure (ADHF).
    
  